JP2003519207A5 - - Google Patents

Download PDF

Info

Publication number
JP2003519207A5
JP2003519207A5 JP2001550189A JP2001550189A JP2003519207A5 JP 2003519207 A5 JP2003519207 A5 JP 2003519207A5 JP 2001550189 A JP2001550189 A JP 2001550189A JP 2001550189 A JP2001550189 A JP 2001550189A JP 2003519207 A5 JP2003519207 A5 JP 2003519207A5
Authority
JP
Japan
Prior art keywords
formula
compound
defined above
enriched
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001550189A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003519207A (ja
Filing date
Publication date
Priority claimed from SE9904850A external-priority patent/SE9904850D0/xx
Application filed filed Critical
Publication of JP2003519207A publication Critical patent/JP2003519207A/ja
Publication of JP2003519207A5 publication Critical patent/JP2003519207A5/ja
Pending legal-status Critical Current

Links

JP2001550189A 1999-12-30 2000-12-22 トルテロジンおよびその類似体の調製方法ならびにこの方法で調製される中間体 Pending JP2003519207A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9904850-6 1999-12-30
SE9904850A SE9904850D0 (sv) 1999-12-30 1999-12-30 Novel process and intermediates
PCT/SE2000/002662 WO2001049649A1 (en) 1999-12-30 2000-12-22 Process of preparing tolterodine and analogues there of as well as intermediates prepared in the process

Publications (2)

Publication Number Publication Date
JP2003519207A JP2003519207A (ja) 2003-06-17
JP2003519207A5 true JP2003519207A5 (enExample) 2007-12-06

Family

ID=20418365

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001550189A Pending JP2003519207A (ja) 1999-12-30 2000-12-22 トルテロジンおよびその類似体の調製方法ならびにこの方法で調製される中間体

Country Status (29)

Country Link
US (1) US6310248B2 (enExample)
EP (2) EP1496045A3 (enExample)
JP (1) JP2003519207A (enExample)
KR (1) KR20020062669A (enExample)
CN (1) CN1209342C (enExample)
AR (1) AR027138A1 (enExample)
AT (1) ATE282019T1 (enExample)
AU (1) AU782796B2 (enExample)
BR (1) BR0016785A (enExample)
CA (1) CA2392832A1 (enExample)
CZ (1) CZ20022255A3 (enExample)
DE (1) DE60015799T2 (enExample)
DK (1) DK1242361T3 (enExample)
EE (1) EE200200325A (enExample)
ES (1) ES2228658T3 (enExample)
HU (1) HUP0203816A3 (enExample)
IL (1) IL150275A0 (enExample)
MX (1) MXPA02006415A (enExample)
MY (1) MY118906A (enExample)
NO (1) NO20023189L (enExample)
NZ (1) NZ519079A (enExample)
PE (1) PE20011123A1 (enExample)
PL (1) PL355947A1 (enExample)
PT (1) PT1242361E (enExample)
SE (1) SE9904850D0 (enExample)
SK (1) SK9392002A3 (enExample)
TW (1) TWI225476B (enExample)
WO (1) WO2001049649A1 (enExample)
ZA (1) ZA200204066B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
US6703504B2 (en) 2002-02-11 2004-03-09 Clarke Slemon Conformationally constrained compounds as dendrimer cores
WO2003064501A1 (en) * 2002-01-31 2003-08-07 Clarke Slemon Conformationally restricted compounds as dendrimer cores
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
ITMI20031354A1 (it) * 2003-07-02 2005-01-03 Istituto Di Chimica Biomolecolare D El Cnr Sezione Sintesis enantioselettiva di composti enantiomericamente arricchiti.
ES2235648B1 (es) * 2003-12-22 2006-11-01 Ragactives, S.L. Procedimiento para la obtencion de tolterodina.
ITMI20040616A1 (it) * 2004-03-30 2004-06-30 Dinamite Dipharma S P A In For Processo per la preparazione di tolterodina e suoi intermedi
EP1629834A1 (en) 2004-08-27 2006-03-01 KRKA, D.D., Novo Mesto Sustained release pharmaceutical composition of tolterodine
ITMI20041920A1 (it) * 2004-10-11 2005-01-11 Chemi Spa Processo per la preparazione di n, n-diisopropil-3-2-idrossi-5-metilfenil-3-fenil-propabammina
JP4513535B2 (ja) * 2004-12-03 2010-07-28 住友化学株式会社 トルテロジンの製造方法
US20080045602A1 (en) * 2004-12-24 2008-02-21 Casar Renata T Process for Preparation of 3-(2-Hydroxy-5Methylphenyl)-N, N-Disopropyl-3-Phenylpropylamine
US7528267B2 (en) * 2005-08-01 2009-05-05 Girindus America, Inc. Method for enantioselective hydrogenation of chromenes
ES2268987B1 (es) 2005-08-05 2008-02-01 Ragactives, S.L. Procedimiento para la obtencion de 3,3-difenilpropilaminas.
KR100647068B1 (ko) 2005-09-15 2006-11-23 하나제약 주식회사 라세믹ｎ,ｎ-디이소프로필-3-(2-히드록시-5-메틸페닐)-3-페닐프로판아민의 제조방법
KR100686351B1 (ko) * 2006-01-12 2007-02-22 주식회사 카이로제닉스 톨테로딘 라세미체의 제조방법
ATE480531T1 (de) 2006-05-24 2010-09-15 Pfizer Ltd Verfahren zur herstellung von benzopyran-2- olderivaten
KR101488740B1 (ko) 2006-06-12 2015-02-03 유씨비 파마 게엠베하 새로운 키랄 중간체, 그 키랄 중간체의 제조방법 및 톨테로딘, 페소테로딘 또는 그 활성대사물질의 제조에서 그키랄 중간체의 사용
KR100717361B1 (ko) * 2006-08-07 2007-05-11 주식회사 카이로제닉스 톨테로딘 라세미체 및 이의 중간체의 제조방법
US8871275B2 (en) 2007-08-08 2014-10-28 Inventia Healthcare Private Limited Extended release compositions comprising tolterodine
MX2011001341A (es) 2008-08-19 2011-03-29 Xenoport Inc Prodrogas de metil hidrogeno fumarato, sus composiciones farmaceuticas, y metodos de uso.
RU2478616C2 (ru) 2008-12-24 2013-04-10 Дайити Санкио Компани, Лимитед Циклические аминосоединения
NZ593676A (en) 2008-12-24 2012-06-29 Daiichi Sankyo Co Ltd Calcium-sensing receptor antagonists
KR101275984B1 (ko) * 2010-10-18 2013-06-18 경기대학교 산학협력단 광학활성을 갖는 크로만계 유도체 및 이의 제조방법
EP2639216B1 (en) * 2010-11-09 2018-07-11 Kaneka Corporation Halogenated indenones and method for producing optically active indanones or optically active indanols by using same
WO2012098044A1 (en) 2011-01-17 2012-07-26 Cambrex Profarmaco Milano S.R.L. Process for the preparation of n,n-diisopropyl-3-(2-hydroxy-5-methylphenyl)- 3-phenyl propylamine and its salts starting from a novel intermediate
EP2476665A1 (en) 2011-01-17 2012-07-18 Cambrex Profarmaco Milano S.r.l. Process for the preparation of N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)- 3-phenyl propylamine and its salts starting from a novel intermediate
LT3135656T (lt) 2011-06-20 2019-04-25 H. Lundbeck A/S Deuterinti 1-piperazin-3-fenilindanai, skirti šizofrenijos gydymui
CN103159657B (zh) * 2011-12-08 2016-06-29 重庆华邦胜凯制药有限公司 一种定向合成不饱和共轭醇的方法
AR094054A1 (es) * 2012-12-19 2015-07-08 H Lundbeck As 6-cloro-3-(fenil-d₅)-inden-1-ona y uso de la misma
KR101380982B1 (ko) 2013-04-29 2014-04-10 경기대학교 산학협력단 광학활성을 갖는 크로만-2-올 유도체 및 이의 제조방법
WO2017137955A1 (en) 2016-02-14 2017-08-17 Celestis Pharmaceuticals Pvt. Ltd. Novel (r) and rac 3-(2-(allyloxy)-5-methylphenyl)-n,n-diisopropyl-3- phenylpropan-1-amine and its use for synthesis of (r) and rac-2-(3- (diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol
WO2018013739A2 (en) * 2016-07-12 2018-01-18 Chromocell Corporation Compounds, compositions, and methods for modulating sweet taste
CN113056457B (zh) 2018-12-03 2025-06-20 H.隆德贝克有限公司 用于治疗cns疾病的前药

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8800207D0 (sv) * 1988-01-22 1988-01-22 Kabivitrum Ab Nya aminer, deras anvendning och framstellning
SE9203318D0 (sv) * 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
ZA969363B (en) 1995-11-08 1997-11-18 Smithkline Beecham Corp An improved process for preparing aromatic ring-fused cyclopentane derivatives.
KR20000057548A (ko) * 1996-12-13 2000-09-25 알프레드 엘. 미첼슨 광학적 전송물질 및 결합재
EP0957073A1 (en) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines

Similar Documents

Publication Publication Date Title
TWI225476B (en) Novel process of preparing tolterodine and analogues thereof, and novel intermediates prepared therein
JP2003525949A5 (enExample)
JP2001261662A5 (enExample)
JP2007511546A5 (enExample)
WO2000012044A3 (en) Method for the preparation of citalopram
CA2359810A1 (en) Process for the preparation of pure citalopram
JP2009538336A5 (enExample)
JP2004504323A5 (enExample)
JP2010509334A5 (enExample)
JP2002506844A5 (enExample)
JP2000063366A5 (enExample)
JP2002533430A5 (enExample)
JP2003531184A5 (enExample)
JP2004520312A5 (enExample)
JP3867250B2 (ja) テトラヒドロインデノ〔１，２−ｄ〕〔１，３，２〕オキサザボロール及びその鏡像異性体選択性触媒としての使用
JP2005529869A5 (enExample)
JP2002516313A5 (enExample)
ATE457972T1 (de) Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
EP1162190A3 (en) Production process of cyclohexenyl methyl ketones
RU93055675A (ru) Способ стереоизбирательного получения гетеробициклического спиртового энантиомера, существенно чистый спиртовой энантиомер, способ получения производного пиперазина
JP2003514794A5 (enExample)
CA2575975A1 (en) Preparation of escitalopram
NO20053176L (no) Fremgangsmate for fremstilling av tolperisonsalter.
JP2004503519A5 (enExample)
JP2006514071A5 (enExample)